Alembic Pharmaceuticals 2020 Annual Report

Alembic Pharmaceuticals' 2019-20 annual report highlights consistent and flexible strategic approaches to value creation across its pharmaceutical operations. The company achieved ₹4,606 crores in net revenue and ₹829 crores in PAT, demonstrating growth across its international generics and domestic branded business segments.